Search Within

Ross Levine

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (69)
  2. Journal Article (56)
  3. Research Letter (4)
  4. Editorial (2)
  5. Review (2)
Groups
  1. Adult Leukemia (133)
  2. Center for Hematologic Malignancies (133)
  3. Department of Medicine (133)
  4. Epidemiology and Biostatistics (133)
  5. Executive Committee, Center for Hematologic Malignancies (133)
  6. GSK Faculty (133)

More Groups

People
  1. Martin Tallman (55)
  2. Maria Arcila (39)
  3. Sean Devlin (39)
  4. Elli Papaemmanuil (37)
  5. Ahmet Zehir (33)
  6. Michael Berger (32)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (12)
  4. 2022 (9)
  5. 2021 (12)
  6. 2020 (12)

More Years

Publications
  1. Blood (57)
  2. Journal of Clinical Oncology (9)
  3. Cancer Research (6)
  4. Blood Advances (5)
  5. Clinical Cancer Research (5)
  6. Leukemia Research (5)

More Publications

Publishers
  1. American Society of Hematology (62)
  2. Nature Publishing Group (18)
  3. American Association for Cancer Research (14)
  4. American Society of Clinical Oncology (10)
  5. Elsevier Ltd (5)
  6. Elsevier Inc. (3)

More Publishers

Results (133)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Minimal residual disease assessment by flow cytometry in AML is an independant prognostic factor even after adjusting for cytogenetic/molecular abnormalities
    Meeting Abstract

    Ganzel, C.; Sun, Z. X.; Gonen, M.; Patel, J. P.; Abdel-Wahab, O.; Fernandez, H. F.; Rowe, J. M.; Tallman, M. S.; Levine, R. L.; Paietta, E. M.
    Blood (2014)

    Fulltext@MSK | Save
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, R.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Laboratory Investigation (2014)

    Fulltext@MSK | Save
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, I.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • High-throughput mutational profiling of post-myeloproliferative neoplasm acute myeloid leukemia reveals frequent mutations in NRAS in JAK2V617F-negative post-MPN AML
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; McKenney, A. S.; Knapp, K. M.; Patel, M.; Wang, K.; Nahas, M. K.; Yelensky, R.; Otto, G. A.; Lipson, D.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Comprehensive mutational profiling in myelodysplastic syndromes treated with decitabine and tretinoin
    Meeting Abstract

    Shih, A. H.; Devlin, S. M.; Dolezal, E. K.; Knapp, K. M.; Wang, K.; Sanford, E. M.; Brennan, T.; Yelensky, R.; Nahas, M.; Otto, G. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Integrated genetic profiling of JAK2 wildtype chronic-phase myeloproliferative neoplasms
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; Patel, J. P.; Knapp, K. M.; Patel, M.; Greenbowe, J. R.; Young, L. E.; He, J.; Wang, K.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Mutational profiling of myeloid malignancies for prediction of disease relapse following allogeneic stem cell transplantation
    Meeting Abstract

    Hanash, A. M.; Devlin, S. M.; Maloy, M.; Knapp, K. M.; Miller, V. A.; Lipson, D.; Stephens, P. J.; Otto, G. A.; Yelensky, R.; Nahas, M. K.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy
    Meeting Abstract

    Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
    Blood (2013)

    Fulltext@MSK | Save